Back

Tumour microenvironments impose translational repression that limits natural killer cell persistence

Aguiar, C. F.; Nosenko, M. A.; Corkish, C.; Keane, C.; Skabytska, Y.; Gardiner, C. M.; Brennan, L.; Sinclair, L. V.; Finlay, D. K.

2026-07-09 immunology
10.64898/2026.07.06.736719 bioRxiv
Show abstract

Natural killer (NK) cells infiltrate many solid tumours, yet the mechanisms that determine their functional heterogeneity across tumour types remain poorly understood. Differences in tumour immunogenicity, inhibitory signalling, and nutrient availability have all been implicated, but unifying explanations are lacking. Here, we compared four syngeneic tumour models implanted at identical anatomical sites to isolate tumour-intrinsic effects on NK-cell fate. Tumour-infiltrating NK cells displayed striking tumour-specific differences in cytokine production, cytotoxic protein expression, and persistence. These differences were not explained by cytokine availability or global features of the tumour metabolic environment. Instead, quantitative proteomics and time-resolved in vivo labelling revealed that NK cells enter tumours in a functionally competent state but rapidly diverge thereafter. In suppressive tumour microenvironments, NK cells undergo early mitochondrial loss, translational repression, and impaired proteostatic responses, accompanied by increased apoptotic priming. These defects result in reduced effector function and failure of intratumoural persistence despite preserved recruitment. In contrast, permissive tumours sustain NK-cell translational capacity, cytokine responsiveness, and long-term residency. Together, these findings identify disruption of translational and mitochondrial homeostasis as a central mechanism limiting NK-cell persistence in solid tumours. This work establishes early tumour-induced defects in protein synthesis and cellular fitness as key constraints on durable NK-cell immunity and provides a framework for restoring effective innate anti-tumour responses.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 0.1%
18.3%
2
Science Immunology
88 papers in training set
Top 0.2%
8.8%
3
eLife
5828 papers in training set
Top 13%
7.8%
4
Nature Communications
5641 papers in training set
Top 21%
7.8%
5
Cell Reports
1498 papers in training set
Top 5%
6.7%
6
The EMBO Journal
309 papers in training set
Top 0.9%
4.8%
50% of probability mass above
7
Nature Immunology
79 papers in training set
Top 0.6%
4.3%
8
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 14%
4.0%
9
Science Signaling
65 papers in training set
Top 0.2%
3.4%
10
Immunity
67 papers in training set
Top 0.6%
3.2%
11
Cancer Immunology Research
35 papers in training set
Top 0.3%
2.8%
12
Science Advances
1243 papers in training set
Top 14%
2.4%
13
European Journal of Immunology
60 papers in training set
Top 0.8%
1.7%
14
Frontiers in Immunology
638 papers in training set
Top 6%
1.7%
15
Cancer Cell
42 papers in training set
Top 0.8%
1.7%
16
EMBO Reports
263 papers in training set
Top 3%
1.7%
17
Nature
645 papers in training set
Top 8%
1.3%
18
Cancer Research
130 papers in training set
Top 3%
0.9%
19
JCI Insight
277 papers in training set
Top 8%
0.8%
20
Communications Biology
993 papers in training set
Top 31%
0.8%
21
Cell
431 papers in training set
Top 10%
0.8%
22
Journal of Experimental Medicine
119 papers in training set
Top 3%
0.6%
23
iScience
1154 papers in training set
Top 41%
0.6%
24
The Journal of Immunology
166 papers in training set
Top 3%
0.6%